NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

WARNING: don't get distracted with Sawston, Sawston, and Sawston. Yes, it may be a game changer with Sawston runup/expansion for the fate of the company, aka the fate of our investment, let alone the interests of existing and future patients, BUT THAT IS ONLY FEASIBLE only if DCVax-L trial is successful and approved by FDA and/or UK, Germany and Canada. IF NOT IT JUST WASTES OF MONEY IN THE END!

The focus in the inquiry of the management must be focused on the trial: status of the trial, how many still living, and when was or will be data lock, unblinding, and publication of topline data?

BESIDES THAT, is there any plan or arrangement in place to sustain the company until topline data announcement, is such plan or arrangement involved significant share dilution?

Is there any plan or arrangement in place/in development so that the company can still move forward to test L and D in other indications or subgroups of GBM patients if the trial fails or BLA rejected?

What's the reason that for years the management seems afraid of promoting its own company? is it because SEC or FDA or is it because the trial was deemed failure some time in the past but not announced? Please give some specific color?

All in all, what we should be concerned the most is the FATE OF THIS TRIAL. IF IT FAILS ALL OTHERS ARE MEANINGLESS!

BE AWARE OF DEFLECTION, DISTRACTION, REGARDLESS ITS FROM THE MANAGEMENT OR SOME POSTERS HERE.

Finally, we are shareholders no questions are bad questions or too blunt to ask.